NVO · Novo Nordisk A S
$47.08
-4.53 (-8.78%)
At close · Jul 31
Market Cap
$228.21B
Shares
4.42B
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-14 | 27,397 | $49.28 | $1,350,124 |
| 2026-07-13 | 2,279 | $49.48 | $112,765 |
| 2026-07-10 | 260 | $48.88 | $12,709 |
| 2026-07-09 | 446 | $48.89 | $21,805 |
| 2026-07-08 | 1,945 | $49.64 | $96,550 |
| 2026-07-07 | 12,083 | $49.26 | $595,209 |
| 2026-07-06 | 1,376 | $50.43 | $69,392 |
| 2026-07-01 | 477 | $47.94 | $22,867 |
| 2026-06-30 | 2,305 | $48.34 | $111,424 |
| 2026-06-29 | 5,400 | $48.07 | $259,578 |
| 2026-06-26 | 8,665 | $47.64 | $412,801 |
| 2026-06-25 | 20,613 | $47.41 | $977,262 |
| 2026-06-24 | 48,411 | $47.42 | $2,295,650 |
| 2026-06-23 | 6,151 | $45.88 | $282,208 |
| 2026-06-18 | 5,353 | $43.52 | $232,963 |
| 2026-06-17 | 3,021 | $43.55 | $131,565 |
| 2026-06-15 | 35,875 | $43.88 | $1,574,195 |
| 2026-06-12 | 284,043 | $43.96 | $12,486,530 |
| 2026-06-09 | 72,382 | $41.02 | $2,969,110 |
| 2026-06-08 | 11,430 | $42.96 | $491,033 |
| 2026-06-03 | 68,495 | $42.92 | $2,939,805 |
| 2026-06-02 | 30 | $44.07 | $1,322 |
| 2026-05-26 | 19,674 | $44.96 | $884,543 |
| 2026-05-19 | 49,736 | $44.28 | $2,202,310 |
| 2026-05-18 | 100 | $44.74 | $4,474 |
| 2026-05-15 | 100 | $45.80 | $4,580 |
| 2026-05-14 | 135 | $47.08 | $6,356 |
| 2026-05-13 | 176,136 | $47.00 | $8,278,392 |
| 2026-05-11 | 796 | $46.07 | $36,672 |
| 2026-05-07 | 34,135 | $45.76 | $1,562,018 |
| 2026-05-04 | 11,567 | $43.88 | $507,560 |
| 2026-05-01 | 7,910 | $42.22 | $333,960 |
Showing 1–32 of 32 settlements
Key facts
CIK
353278
CUSIP
670100205
13F (30d)
580 filings
543 filers
Visit website
Investor relations